NewsBenzingaBioNTech evalúa los próximos pasos mientras el medicamento contra el cáncer de mama muestra un beneficio limitado para los pacientes BioNTech evalúa los próximos pasos mientras el medicamento contra el cáncer de mama muestra un beneficio limitado para los pacientes Benzinga 2026.10.26 13:31 (GMT+0) Open on Benzinga Other news Intel Shares Fall 3.3% Pre-Market After Nvidia Cuts Its Stake in the Company by 25% Bitcoin, Ether Lose Over 13% in Week as Rebound Fades NRX Pharmaceuticals Q3 EPS $(0.05) Beats $(0.21) Estimate, Sales $1.159M Miss $1.300M Estimate HUYA Q3 Adj. EPS $0.03 Up From $0.02 YoY, Sales $261.441M Up From $237.147M YoY Adam Schiff Slams Corporate Executives Over Unreturned Trump Tariff Money: ‘Companies Got Tariff Refunds, Consumers Got…’ KOSPI Closes Below 5,000 as Chip Stocks Extend Slide
Adam Schiff Slams Corporate Executives Over Unreturned Trump Tariff Money: ‘Companies Got Tariff Refunds, Consumers Got…’